PURECYCLE TECHNOLOGIES INC (PCT)

US74623V1035 - Common Stock

11.93  +0.24 (+2.05%)

After market: 12.1895 +0.26 (+2.18%)

Fundamental Rating

2

Taking everything into account, PCT scores 2 out of 10 in our fundamental rating. PCT was compared to 85 industry peers in the Chemicals industry. PCT has a bad profitability rating. Also its financial health evaluation is rather negative. PCT does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

In the past year PCT has reported negative net income.
In the past year PCT has reported a negative cash flow from operations.
PCT had negative earnings in each of the past 5 years.
In the past 5 years PCT always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of PCT (-9.79%) is worse than 82.35% of its industry peers.
PCT has a worse Return On Equity (-24.20%) than 82.35% of its industry peers.
Industry RankSector Rank
ROA -9.79%
ROE -24.2%
ROIC N/A
ROA(3y)-10.43%
ROA(5y)-6.53%
ROE(3y)-20.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

PCT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

The number of shares outstanding for PCT has been increased compared to 1 year ago.
The debt/assets ratio for PCT is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.26, we must say that PCT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.26, PCT is not doing good in the industry: 70.59% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.21 is on the high side and indicates that PCT has dependencies on debt financing.
With a Debt to Equity ratio value of 1.21, PCT is not doing good in the industry: 72.94% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Altman-Z 1.26
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 2.92 indicates that PCT has no problem at all paying its short term obligations.
PCT has a Current ratio of 2.92. This is in the better half of the industry: PCT outperforms 80.00% of its industry peers.
A Quick Ratio of 2.92 indicates that PCT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.92, PCT belongs to the top of the industry, outperforming 89.41% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.92
Quick Ratio 2.92

3

3. Growth

3.1 Past

The earnings per share for PCT have decreased by -3.51% in the last year.
EPS 1Y (TTM)-3.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

PCT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.21% yearly.
PCT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 494.58% yearly.
EPS Next Y-93.4%
EPS Next 2Y4.58%
EPS Next 3Y11.21%
EPS Next 5YN/A
Revenue Next Year10916.8%
Revenue Next 2Y2508.1%
Revenue Next 3Y1060.79%
Revenue Next 5Y494.58%

3.3 Evolution

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PCT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PCT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.58%
EPS Next 3Y11.21%

0

5. Dividend

5.1 Amount

PCT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PURECYCLE TECHNOLOGIES INC

NASDAQ:PCT (11/22/2024, 8:00:00 PM)

After market: 12.1895 +0.26 (+2.18%)

11.93

+0.24 (+2.05%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.07B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.79%
ROE -24.2%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.92
Quick Ratio 2.92
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-3.51%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-93.4%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y